Rznomics (CEO Seong-wook Lee, Graduate Bio-convergence Engineering Department) a subsidiary of the Industry-Academic Cooperation Group received the Chairman's Award of Central Holdings at the "2024 Korea Innovation Startup Award" selected by the Korea Advanced Institute of Science and Technology (KAIST) as an outstanding R&D-based K-Deep Tech company.

Deep-locked technology that has not yet been discovered is called deep-tech. The "Korea Innovation Startup Award" is supporting deep-tech startups armed with innovative technologies and creative IDs to establish themselves as growth engines for the Korean economy.

KAIST, Seoul National University, and Central Holdings cooperated and sponsored by the Ministry of Science and ICT. The award ceremony was held at the "Korea International Symposium 2024 for Innovative Start-up Countries" held at Seoul National University on the 11th (Wednesday).

Based on RNA editing technology, Rznomics Inc., founded in 2017, is innovating biotechnology and opening a new horizon in the development of new drugs by developing gene therapy drugs for rare and intractable diseases. KAIST and Seoul National University praised Rznomics Inc.'s technological prowess and recent achievements.

The key to Rznomics Inc.'s technology is to remove RNA that causes cancer or genetic diseases and at the same time substitute 1:1 therapeutic RNA at the cut RNA site. △ Domestic and foreign patent registration △ Clinical approval of anticancer gene therapy products by the Korea Food and Drug Administration (FDA) △ Clinical approval by the Australian Federal Drug Administration (TGA) for genetic disease gene therapy products.

Recently, the U.S. Food and Drug Administration (FDA) designated rare drugs for liver cancer of the anticancer drug "RZ-001" and designated a fast track for brain cancer, and was selected as the first in the research and development field of the government-recognized national strategic technology confirmation system.

Professor Seong-wook Lee said, "I am happy to be recognized for the progressiveness and innovation of the company's technology through the award of the Korea Innovation Startup Award," adding, "We will do our best to contribute to the development of advanced technologies in the bio sector and the future growth of the country."

Professor Seong-wook Lee's research team, who has been silently researching RNA editing technology at our university for the past 20 years, is happy to be recognized for its technological prowess as another innovative start-up award, President Ahn Soon-cheol said. "Our university will lead the industry-academic cooperation ecosystem to an entrepreneurial university by discovering and supporting teachers who will write the myth of the 'Second Rznomics-Professor Seong-wook Lee'."